ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 37 of 103 for:    "androgenetic alopecia" OR "female pattern baldness" OR "male pattern baldness"

The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02594046
Recruitment Status : Completed
First Posted : November 2, 2015
Last Update Posted : April 5, 2017
Sponsor:
Information provided by (Responsible Party):
Sang Yeoup Lee, Pusan National University Hospital

Brief Summary:
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.

Condition or disease Intervention/treatment Phase
Androgenic Alopecia Other: stem cell component extract Not Applicable

Detailed Description:
This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 38 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Supportive Care
Official Title: The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia
Study Start Date : July 1, 2015
Actual Primary Completion Date : February 28, 2016
Actual Study Completion Date : May 28, 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: stem cell group
stem cell group who apply 1.2 g of allogeneic human adipose derived stem cell component extract on their scalp for 16 weeks
Other: stem cell component extract
The Allogeneic Human adipose derived stem cell component extract
Other Name: Tiara hair toninc

Placebo Comparator: placebo group
placebo group who apply a placebo on their scalp for 16 weeks
Other: stem cell component extract
The Allogeneic Human adipose derived stem cell component extract
Other Name: Tiara hair toninc




Primary Outcome Measures :
  1. change of total hair counts by phototrichogram [ Time Frame: 16 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years to 59 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • androgenic alopecia basic and specific(BASP) classification: M2, C2, U1, V1, or F1 or higher

Exclusion Criteria:

  • patient of scalp disease

Responsible Party: Sang Yeoup Lee, professor, Pusan National University Hospital
ClinicalTrials.gov Identifier: NCT02594046     History of Changes
Other Study ID Numbers: L-2015-199-2
First Posted: November 2, 2015    Key Record Dates
Last Update Posted: April 5, 2017
Last Verified: April 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Alopecia
Alopecia Areata
Hypotrichosis
Hair Diseases
Skin Diseases
Pathological Conditions, Anatomical